FLUDROCORTISONE Drug Patent Profile
✉ Email this page to a colleague
When do Fludrocortisone patents expire, and when can generic versions of Fludrocortisone launch?
Fludrocortisone is a drug marketed by Barr, Chartwell Rx, Hibrow Hlthcare, Hikma Pharms, Impax Labs, Novitium Pharma, and Zydus Lifesciences. and is included in seven NDAs.
The generic ingredient in FLUDROCORTISONE is fludrocortisone acetate. There are four drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the fludrocortisone acetate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Fludrocortisone
A generic version of FLUDROCORTISONE was approved as fludrocortisone acetate by IMPAX LABS on March 18th, 2002.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for FLUDROCORTISONE?
- What are the global sales for FLUDROCORTISONE?
- What is Average Wholesale Price for FLUDROCORTISONE?
Summary for FLUDROCORTISONE
| US Patents: | 0 |
| Applicants: | 7 |
| NDAs: | 7 |
| Drug Prices: | Drug price information for FLUDROCORTISONE |
| DailyMed Link: | FLUDROCORTISONE at DailyMed |
US Patents and Regulatory Information for FLUDROCORTISONE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Barr | FLUDROCORTISONE ACETATE | fludrocortisone acetate | TABLET;ORAL | 040425-001 | Jan 21, 2003 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Zydus Lifesciences | FLUDROCORTISONE ACETATE | fludrocortisone acetate | TABLET;ORAL | 219251-001 | Oct 16, 2024 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Hikma Pharms | FLUDROCORTISONE ACETATE | fludrocortisone acetate | TABLET;ORAL | 091302-001 | Jul 22, 2011 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Chartwell Rx | FLUDROCORTISONE ACETATE | fludrocortisone acetate | TABLET;ORAL | 216013-001 | Oct 27, 2022 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Hibrow Hlthcare | FLUDROCORTISONE ACETATE | fludrocortisone acetate | TABLET;ORAL | 220308-001 | Feb 10, 2026 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
